APA (7th ed.) Citation

Bowcock, S., Atkin, C., Iqbal, G., Pratt, G., Yong, K., Neal, R. D., . . . Drayson, M. T. (2023). Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial. Cancers, 15(13), 3337. https://doi.org/10.3390/cancers15133337

Chicago Style (17th ed.) Citation

Bowcock, Stella, et al. "Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial." Cancers 15, no. 13 (2023): 3337. https://doi.org/10.3390/cancers15133337.

MLA (9th ed.) Citation

Bowcock, Stella, et al. "Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial." Cancers, vol. 15, no. 13, 2023, p. 3337, https://doi.org/10.3390/cancers15133337.